HIV [clinicaltrials_resource:abc5a56c92b789ec8de46f7818b24649]
Continuing Care and Treatment for Patients With Cancer/AIDS/Skin Disease [clinicaltrials:NCT00001295]Tissue Biopsy and Imaging Studies in HIV-Infected Patients [clinicaltrials:NCT00001471]Specimen Collections From Patients With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer [clinicaltrials:NCT00006518]Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Primary and Chronic HIV-Infected Patients [clinicaltrials:NCT00039689]Health Values and Spirituality in Veterans With HIV/AIDS [clinicaltrials:NCT00057109]Painful HIV Neuropathy and Alpha-Lipoic Acid [clinicaltrials:NCT00079807]clinicaltrials:NCT00092222Interluekin-7 to Treat HIV-Infected People Receiving Antiretroviral Treatment [clinicaltrials:NCT00105417]Study of Lifestyle Modification in HIV Lipodystrophy [clinicaltrials:NCT00111358]Impact of Cotrimoxazole Prophylaxis for HIV-Infected Adults on Antifolate Resistance [clinicaltrials:NCT00137657]Mother-Infant Rapid Intervention at Delivery Telephone Outreach for Neonatal Therapy (TOT) Trial. [clinicaltrials:NCT00139087]Switching From Zidovudine to an NNRTI or Lopinavir/Ritonavir in Patients Treated With Zidovudine/ Lamivudine/Abacavir. [clinicaltrials:NCT00139178]NRTI-Sparing Pilot Study [clinicaltrials:NCT00143689]In-Vivo Response of P. Falciparum to Antimalarial Treatment in HIV-Infected and HIV-Uninfected Adults [clinicaltrials:NCT00144352]Behavioral Intervention Trial for HIV-infected Injection Drug Users [clinicaltrials:NCT00146445]Housing and Health Study [clinicaltrials:NCT00153504]Project TEAM: Teaching HIV Prevention in the HIV Clinic [clinicaltrials:NCT00164320]The Treatment Advocacy Program [clinicaltrials:NCT00164333]Computer-Assisted HIV Prevention for Young Drug Users [clinicaltrials:NCT00182585]Reducing Risk and Trauma-Related Stress in Persons Living With HIV [clinicaltrials:NCT00186030]Group Psychotherapy for People With HIV [clinicaltrials:NCT00186550]A Case Management Intervention to Prevent ER Visits in HIV-infected Persons [clinicaltrials:NCT00187590]Structured Treatment Interruption for HIV Patients With Virologic Failure [clinicaltrials:NCT00188851]Single-dose Postpartum Vitamin A Supplementation of Mothers and Neonates [clinicaltrials:NCT00198718]A Pilot Study of Triple NtRTI/NsRTI Therapy in Antiretroviral Naive HIV-1 Infected Patients [clinicaltrials:NCT00199121]The Effects of Anabolic Steroids and Protease Inhibitors on People Living With HIV/AIDS [clinicaltrials:NCT00202241]Maternal TDF and FTC to Reduce NNRTI Resistance Mutations After Intrapartum NVP [clinicaltrials:NCT00204308]clinicaltrials:NCT00218335Safer Choices 2 - HIV, STD, & Pregnancy Prevention Program [clinicaltrials:NCT00223314]Evaluation of Viral Efficacy and Safety of a Reduced Dose of Stavudine (d4T): THE PHOENIX STUDY [clinicaltrials:NCT00235222]The Efficacy of the HIV/AIDS Symptom Management Manual [clinicaltrials:NCT00241202]A Study to Assess the Effectiveness of PROCRIT (Epoetin Alfa) Dosing Every 2 Weeks Versus Once a Week in Anemic HIV-infected Patients [clinicaltrials:NCT00246298]High Dose Ritonavir/Lopinavir Liquid Formulation in Salvage Therapy for Protease Inhibitor Resistant HIV Disease [clinicaltrials:NCT00247143]A Theory Based HIV Prevention Video For Rapid HIV Testing: A Randomized Trial [clinicaltrials:NCT00250549]Motivating HIV+ Women: Risk Reduction and ART Adherence [clinicaltrials:NCT00253045]TMC125-C206: A Phase III Study to Investigate the Efficacy, Tolerability and Safety of TMC125 as Part of an Antiretroviral Regimen, Including TMC114/Ritonavir and an Investigator-selected Optimized Background, in HIV-1 Infected Patients With Limited to no Treatment Options. [clinicaltrials:NCT00254046]TMC125-C216: A Phase III Study to Investigate the Efficacy, Tolerability and Safety of TMC125 as Part of an Antiretroviral Regimen, Including TMC114/Ritonavir and an Investigator-selected Optimized Background, in HIV-1 Infected Patients With Limited to no Treatment Options. [clinicaltrials:NCT00255099]Intervention Development for Newly Diagnosed Youth With HIV [clinicaltrials:NCT00255892]TMC114-C211: Trial of an Investigational Protease Inhibitor TMC114 With Ritonavir ("TMC114/r") in HIV-1 Infected Patients Who Have Never Been Treated With Antiretroviral Medications. [clinicaltrials:NCT00258557]Imaging Trial of the Distribution of Topical Gel in the Human Vagina: Enhanced MRI Techniques to Increase Resolution [clinicaltrials:NCT00260767]
condition [clinicaltrials_vocabulary:condition]
eligibility for clinicaltrials:NCT01301755 [clinicaltrials_resource:02421b9787887627d9853a70e4283bca]eligibility for clinicaltrials:NCT00840840 [clinicaltrials_resource:0752d865b1f003fc9a375f0153a1ac7e]eligibility for clinicaltrials:NCT02236234 [clinicaltrials_resource:0b4ede06f72bdcaec7f2fc11055fda84]eligibility for clinicaltrials:NCT00840099 [clinicaltrials_resource:4735c10d4b998eef28cf97e9aec6b933]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
eligibility for clinicaltrials:NCT01301755 [clinicaltrials_resource:02421b9787887627d9853a70e4283bca]eligibility for clinicaltrials:NCT00840840 [clinicaltrials_resource:0752d865b1f003fc9a375f0153a1ac7e]eligibility for clinicaltrials:NCT02236234 [clinicaltrials_resource:0b4ede06f72bdcaec7f2fc11055fda84]eligibility for clinicaltrials:NCT00840099 [clinicaltrials_resource:4735c10d4b998eef28cf97e9aec6b933]eligibility for clinicaltrials:NCT01046214 [clinicaltrials_resource:501bacbd429d461f755f683db77ff819]eligibility for clinicaltrials:NCT01766700 [clinicaltrials_resource:62c448b723a3c08b04f41614a1016abc]eligibility for clinicaltrials:NCT01938911 [clinicaltrials_resource:79d7a502c3802b7d4927a74e9e18428a]eligibility for clinicaltrials:NCT00790400 [clinicaltrials_resource:e0c6b6e5aba4436861ee6650462f9cfa]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
HIV [clinicaltrials_resource:abc5a56c92b789ec8de46f7818b24649]
Bio2RDF identifier
abc5a56c92b789ec8de46f7818b24649
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:abc5a56c92b789ec8de46f7818b24649
identifier
clinicaltrials_resource:abc5a56c92b789ec8de46f7818b24649
title
HIV
@en
label
HIV [clinicaltrials_resource:abc5a56c92b789ec8de46f7818b24649]
@en